Skip to main content
Premium Trial:

Request an Annual Quote

IBM Watson for Oncology Introduced to 21 Chinese Hospitals

NEW YORK (GenomeWeb) – IBM and Hangzhou CognitiveCare announced that 21 hospitals across China plan to adopt Watson for Oncology in order to help their clinicians better personalize cancer treatments for their patients.

The partners said the initial 21-hospital deal is part of a multi-year partnership that plans to introduce Watson to several more hospitals across China. Hangzhou CognitiveCare will provide sales, service, and customer support, including localizing Watson's results and analysis for doctors in China, and providing some translation services for drug labels and treatment guidelines.

Watson for Oncology draws from more than 300 medical journals, more than 200 textbooks, and nearly 15 million pages of text, IBM said. It provides recommendations about different drug options and administration instructions, as well as information from various treatment guidelines.

"Hangzhou CognitiveCare is eager to bring IBM's Watson for Oncology to reach every oncologist in China we possibly can," said CEO Zhen Tu in a statement. "Watson has the power to transform how doctors battle cancer in China and around the world, providing physicians with insights regarding treatment options that help them customize therapeutic recommendations specific to each individual, based on a patient's specific needs."

Financial terms of the deal were not disclosed.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.